The rapid evolution of the COVID-19 pandemic has sparked a large unmet need for new or additional medical technology and healthcare services to be made available urgently. Healthcare, Academic, Government and Industry organizations and individuals have risen to this challenge by designing, developing, manufacturing or implementing innovation. However, both they and healthcare stakeholders are hampered as it is unclear how to introduce and deploy the products of this innovation quickly and legally within the healthcare system. Our paper outlines the key regulations and processes innovators need to comply with, and how these change during a public health emergency via dedicated exemptions. Our work includes references to the formal documents regarding UK healthcare regulation and governance, and is meant to serve as a guide for those who wish to act quickly but are uncertain of the legal and regulatory pathways that allow new a device or service to be fast-tracked.